Similar articles for PMID: 29628899

Year	Number of Results
2003	4
2004	2
2005	3
2006	1
2008	2
2010	2
2011	4
2012	1
2013	2
2014	6
2015	4
2016	7
2017	11
2018	12
2019	8
2020	2
2024	0

1

Editorial: Advances in Mechanisms of Renal Fibrosis.

Lan HY, Nikolic-Paterson DJ. Lan HY, et al. Front Physiol. 2018 Mar 23;9:284. doi: 10.3389/fphys.2018.00284. eCollection 2018. Front Physiol. 2018. PMID: 29628899 Free PMC article. No abstract available.

2

Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis via regulation of TGF-β/Smad signaling pathway.

Zou GL, Zuo S, Lu S, Hu RH, Lu YY, Yang J, Deng KS, Wu YT, Mu M, Zhu JJ, Zeng JZ, Zhang BF, Wu X, Zhao XK, Li HY. Zou GL, et al. World J Gastroenterol. 2019 Aug 14;25(30):4222-4234. doi: 10.3748/wjg.v25.i30.4222. World J Gastroenterol. 2019. PMID: 31435175 Free PMC article.

3

A Novel Inhibitor of Homeodomain Interacting Protein Kinase 2 Mitigates Kidney Fibrosis through Inhibition of the TGF-β1/Smad3 Pathway.

Liu R, Das B, Xiao W, Li Z, Li H, Lee K, He JC. Liu R, et al. J Am Soc Nephrol. 2017 Jul;28(7):2133-2143. doi: 10.1681/ASN.2016080841. Epub 2017 Feb 20. J Am Soc Nephrol. 2017. PMID: 28220029 Free PMC article.

4

New insights into TGF-β/Smad signaling in tissue fibrosis.

Hu HH, Chen DQ, Wang YN, Feng YL, Cao G, Vaziri ND, Zhao YY. Hu HH, et al. Chem Biol Interact. 2018 Aug 25;292:76-83. doi: 10.1016/j.cbi.2018.07.008. Epub 2018 Jul 11. Chem Biol Interact. 2018. PMID: 30017632 Review.

5

Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway.

Kim D, Lee AS, Jung YJ, Yang KH, Lee S, Park SK, Kim W, Kang KP. Kim D, et al. Nephrol Dial Transplant. 2014 Nov;29(11):2043-53. doi: 10.1093/ndt/gfu240. Epub 2014 Jul 16. Nephrol Dial Transplant. 2014. PMID: 25031017

6

TGF-β/Smad signaling in kidney disease.

Lan HY, Chung AC. Lan HY, et al. Semin Nephrol. 2012 May;32(3):236-43. doi: 10.1016/j.semnephrol.2012.04.002. Semin Nephrol. 2012. PMID: 22835454 Review.

7

Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.

Chen L, Yang T, Lu DW, Zhao H, Feng YL, Chen H, Chen DQ, Vaziri ND, Zhao YY. Chen L, et al. Biomed Pharmacother. 2018 May;101:670-681. doi: 10.1016/j.biopha.2018.02.090. Epub 2018 Mar 22. Biomed Pharmacother. 2018. PMID: 29518614 Review.

8

HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells.

Hofmann TG, Stollberg N, Schmitz ML, Will H. Hofmann TG, et al. Cancer Res. 2003 Dec 1;63(23):8271-7. Cancer Res. 2003. PMID: 14678985

9

Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation.

Yuan Q, Wang R, Peng Y, Fu X, Wang W, Wang L, Zhang F, Peng Z, Ning W, Hu G, Wang Z, Tao L. Yuan Q, et al. Am J Nephrol. 2011;34(2):181-94. doi: 10.1159/000329080. Epub 2011 Jul 23. Am J Nephrol. 2011. PMID: 21791914

10

Smad signaling coincides with epithelial-mesenchymal transition in a rat model of intrauterine adhesion.

Guo LP, Chen LM, Chen F, Jiang NH, Sui L. Guo LP, et al. Am J Transl Res. 2019 Aug 15;11(8):4726-4737. eCollection 2019. Am J Transl Res. 2019. PMID: 31497194 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

65 results

Results by year